当前位置: X-MOL首页全球导师 国内导师 › 鞠曹云

个人简介

中国药科大学副研究员,博士/硕士研究生导师。以第一作者或共通讯作者在Sci Transl Med、Adv Drug Deliv Rev、ACS nano、Acta Pharm Sin B、Nano Lett、Angew Chem Int Ed(VIP,Back cover story)、Small(Inside cover story)、J Control Release等国际顶尖杂志上发表SCI论文二十余篇。获授权发明专利6项。已主持完成国家自然科学基金青年项目1项,中央高校重点项目1项,在研国家自然科学基金面上项目1项,参与国自然重点项目及重大研究计划集成项目各1项。 2016.4-至今 中国药科大学 特聘副研究员/副研究员

研究领域

药用功能材料与核酸递送系统的研究

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Reprogrammed siTNFa/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy 2023-02-01 ACTA PHARMACEUTICA SINICA B 第二通讯作者 Sensitizing Tumors to Immune Checkpoint Blockage via STING Agonists Delivered by Tumor-Penetrating Neutrophil Cytopharmaceuticals 2023-01-01 ACS NANO 第二通讯作者 Neutrophil Cyto-Pharmaceuticals Suppressing Tumor Metastasis via Inhibiting Hypoxia-Inducible Factor-1 alpha in Circulating Breast Cancer Cells 2022-02-01 ADVANCED HEALTHCARE MATERIALS 第二通讯作者 Cytopharmaceuticals: An emerging paradigm for drug delivery 2020-12-01 JOURNAL OF CONTROLLED RELEASE 第二通讯作者 Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy 2020-11-01 SCIENCE TRANSLATIONAL MEDICINE 第二通讯作者 Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment 2020-02-01 CARBOHYDRATE POLYMERS 第二通讯作者 Recognition, Intervention, and Monitoring of Neutrophils in Acute Ischemic Stroke 2019-07-01 NANO LETTERS 共同通讯 Co-delivery of TRAIL and siHSP70 using hierarchically modular assembly formulations achieves enhanced TRAIL-resistant cancer therapy 2019-06-01 JOURNAL OF CONTROLLED RELEASE 共同通讯 Neoadjuvant Chemotherapy Based on Abraxane/Human Neutrophils Cytopharmaceuticals with Radiotherapy for Gastric Cancer 2019-02-01 SMALL 其他 Self-assembled micelles based on N-octyl-N’-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel 2018-12-01 Carbohydrate Polymers 第二通讯作者

推荐链接
down
wechat
bug